Obesity is a growing global health problem. Since increased oxidative stress is one of the key pathological mechanisms underpinning overweight and strongly correlates with progression of obesity-related complications we hypothesized that C60 fullerene nanoparticles, due to their strong antioxidant capacity, could be the promising therapeutic agent in the treatment of this disease. Here we investigated whether the C60 fullerenes can alleviate diet-induced obesity (DIO) and metabolic impairments associated with it.
To determine the effect of C60 fullerenes on some nutritional and metabolic parameters, rats were fed either a normal diet (6.7% fat, 15.27 kJ·g−1) or a high-fat diet (38.8% fat, 28.71 kJ·g−1) for 70 days and were simultaneously treated per os with pristine C60 fullerene aqueous solution (C60FAS; 0.3 mg·kg−1 every other day) since the 28th day from the start of the experiment.
Rats fed with high fat diet had significantly increased body mass index (BMI), levels of insulin, glucose, glycosilated hemoglobin (HbA1c) and serum pro-inflammatory cytokines compared with control rats fed with low-fat chow. C60 fullerenes normalized the metabolic parameters and partially reduced BMI in DIO animals. Pro-inflammatory cytokines (IL-1b, IL-12, INFγ) were also decreased in serum of DIO rats treated with C60 fullerenes while anti-inflammatory cytokines (IL-4, IL-10) were at the control levels. High fat diet caused the increased level of oxidative stress products, and this was accompanied by decreased activity both the superoxide dismutase and catalase, whereas the administration of C60 fullerenes markedly decreased level of oxidative stress and enhanced antioxidant enzyme activities.
These data indicate that water-soluble pristine C60 fullerenes reduce chronic inflammation, restore glucose homeostasis as well as positively affects on prooxidant-antioxidant homeostasis. C60 fullerenes could be represented as a promising therapeutic agent in the treatment of obesity and its related complications.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Effect of the deuterium on efficiency and type of adipogenic differentiation of human adipose-derived stem cells in vitro
Scientific Reports Open Access 23 March 2020
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
World Health Organization, WHO, Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation (WHO Technical Report Series 894), http://www.who.int/nutrition/publications/obesity/WHO_TRS_894/en/, (accessed 10 Feb 2016).
Malnick SD, Knobler H. The medical complications of obesity. QJM. 2006;99:565–79.
Segula D. Complications of obesity in adults: A short review of the literature. Malawi Med J. 2014;26:20–4.
Qatanani M, Lazar MA. Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev. 2007;21:1443–55.
Golay A, Ybarra J. Link between obesity and type 2 diabetes. Best Pract Res Clin Endocrinol Metab. 2005;19:649–63.
Novelli ELB, Fernandes A, Campos K, Diniz Y, Almeida J, Ribas BO. The adverse effects of a high-energy dense diet on cardiac tissue. Journal of Nutritional and Environmental Medicine. 2002;12:287–90.
Bianchini F, Kaaks R, Vainiuo H. Overweight, obesity and cancer risk. Lancet Oncology. 2002;3:565–74.
Mafort TT, Rufino R, Costa CH, Lopes AJ. Obesity: systemic and pulmonary complications, biochemical abnormalities, and impairment of lung function. Multidiscip. Resp. Med. 2016;11:28.
Marseglia L, Manti S, D’Angelo G, Nicotera A, Parisi E, Di Rosa G, et al. Oxidative stress in obesity: a critical component in human diseases. Int J Mol Sci. 2014;16:378–400.
Serra D, Mera P, Malandrino MI, Mir JF, Herrero L. Mitochondrial fatty acid oxidation in obesity. Antioxid Redox Signal. 2013;19:269–84.
Tiganis T. Reactive oxygen species and insulin resistance: the good, the bad and the ugly. Trends Pharmacol Sci. 2011;32:82–9.
Sakai K, Matsumoto K, Nishikawa T, Suefuji M, Nakamaru K, Hirashimaet Y, et al. Mitochondrial reactive oxygen species reduce insulin secretion by pancreatic beta-cells. Biochem Biophys Res Commun. 2003;300:216–22.
Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004;114:1752–61.
Rocca A, Moscato S, Ronca F, Nitti S, Mattoli V, Giorgi M, et al. Pilot in vivo investigation of cerium oxide nanoparticles as a novel anti-obesity pharmaceutical formulation. Nanomedicine. 2015;11:1725–34.
Bogdanović G, Djordjević A. Carbon nanomaterials: Biologically active fullerene derivatives. Srp Arh Celok Lek. 2016;144:222–31.
Prylutskyy YI, Yashchuk VM, Kushnir KM, et al. Biophysical studies of fullerene-based composite for bio-nanotechnology. Mater. Sci. Engineer. C. 2003;23:109–11.
Prylutskyy YI, Petrenko VI, Ivankov OI, Golub AA, Kudrenko VA, Prylutska SV, et al. On the origin of C60 fullerene solubility in aqueous solution. Langmuir. 2014;30:3967–70.
Ritter U, Prylutskyy YI, Evstigneev MP, Davidenko NA, Cherepanov VV, Senenko AI, et al. Structural features of highly stable reproducible C60 fullerene aqueous colloid solution probed by various techniques. Fullerenes, Nanotubes, Carbon Nanostruct. 2015;23:530–34.
Foley S, Crowley C, Smaihi M, Bonfils C, Erlanger BF, Seta P, et al. Cellular localisation of a water-soluble fullerene derivative. Biochem Biophys Res Commun. 2002;294:116–9.
Schuetze C, Ritter U, Scharff P, Bychko A, Prylutska S, Rybalchenko V, et al. Interaction of N-fluorescein-5-isothiocyanate pyrrolidine-C60 compound with a model bimolecular lipid membrane. Mater. Sci. Engineer. C. 2011;31:1148–50.
Franskevych D, Palyvoda K, Petukhov D, Prylutska S, Grynyuk I, Schuetze C, et al. Fullerene C60 penetration into leukemic cells and its photoinduced cytotoxic effects. Nanoscale Res Lett. 2017;12:40.
Wang IC, Tai LA, Lee DD, Kanakamma PP, Shen CK, Luh TY, et al. C(60) and water-soluble fullerene derivatives as antioxidants against radical-initiated lipid peroxidation. J Med Chem. 1999;42:4614–20.
Burlaka АP, Sidorik ЕP, Prylutska SV, Маtyshevska ОP, Golub АА, Prylutskyy YI, et al. Catalytic system of the reactive oxygen species on the C60 fullerene basis. Exp Oncol. 2004;26:326–27.
Gharbi N, Pressac M, Hadchouel M, Szwarc H, Wilson SR, Moussa F. fullerene is a powerful antioxidant in vivo with no acute or subacute toxicity. Nano Lett. 2005;5:2578–85.
Youle RJ, Karbowski M. Opinion: mitochondrial fission in apoptosis. Nature Rev. Mol. Cell. Biol. 2005;6:657–63.
Sayes CM, Fortner JD, Guo W, Lyon D, Boyd AM, Ausman KD, et al. The differential cytotoxicity of water-soluble fullerenes. Nano Lett. 2004;4:1881–87.
Prylutska SV, Matyshevska OP, Golub AА, Prylutskyy YI, Potebnya GP, Ritter U, Scharff P. Study of С60 fullerenes and С60-containing composites cytotoxicity in vitro. Mater. Sci. Engineer. C. 2007;27:1121–4.
Prylutska SV, Grynyuk II, Grebinyk SM, Matyshevska OP, Prylutskyy YI, Ritter U, et al. Comparative study of biological action of fullerenes C60 and carbon nanotubes in thymus cells. Mat.-wiss. u. Werkstofftech. 2009;40:238–41.
Tolkachov M, Sokolova V, Korolovych V, Prylutskyy Yu, Epple M, Ritter U, et al. Study of biocompatibility effect of nanocarbon particles on various cell types in vitro. Mat.-wiss. u. Werkstofftech. 2016;47:216–21.
Halenova TI, Vareniuk IM, Roslova NM, Dzerzhynsky ME, Savchuk OM, Ostapchenko LI, et al. Hepatoprotective effect of orally applied water-soluble pristine C60 fullerene against CCl4-induced acute liver injury in rats. RSC Adv. 2016;6:100046–55.
Prylutskyy YI, Vereschaka IV, Maznychenko AV, Bulgakova NV, Gonchar OO, Kyzyma OA, et al. C60 fullerene as promising therapeutic agent for correcting and preventing skeletal muscle fatigue. J Nanobiotechnology. 2017;15:8.
Lynchak OV, Prylutskyy YuI, Rybalchenko VK, Kyzyma OA, Soloviov D, Kostjukov VV, et al. Comparative analysis of the antineoplastic activity of C60 fullerene with 5-fluorouracil and pyrrole derivative in vivo. Nanoscale Res Lett. 2017;12:8.
Scharff P, Carta-Abelmann L, Siegmund C, Matyshevska OP, Prylutska SV, Koval TV, et al. Effect of X-ray and UV irradiation of the C60 fullerene aqueous solution on biological samples. Carbon N Y. 2004;42:1199–201.
Kuklin AI, Islamov AKh, Gordeliy VI. Two-detector system for small-angle neutron scattering instrument. Neutron News. 2005;16:16–8.
Soloviev AG, Solovieva TM, Stadnik AV, Islamov AH, Kuklin AI. The upgrade of package for preliminary treatment of small-angle scattering spectra. JINR Commun. 2003;10:2003–86.
Shen XH, Tang QY, Huang J, Cai W. Vitamin E regulates adipocytokine expression in a rat model of dietary-induced obesity. Exp Biol Med (Maywood). 2010;235:47–51.
Novelli EL, Diniz YS, Galhardi CM, Ebaid GM, Rodrigues HG, Mani F, et al. Anthropometrical parameters and markers of obesity in rats Laboratory Animals Ltd. Lab Anim. 2007;41:111–19.
Nedzvetsky V, Andrievsky G, Chachibaia T, Tykhomyrov A. Differences in antioxidant/protective efficacy of hydrated C60 fullerene nanostructures in liver and brain of rats with streptozotocin-induced diabetes. J. Diabetes Metab. 2012;3:2–9.
Sirota TV. A novel approach to study the reaction of adrenaline autooxidation: A possibility for polarographic determination of superoxide dismutase activity and antioxidant properties of various preparations. Biochemistry. 2011;3:253–9.
Korolyuk MA, Ivanova LI, Maiorova IG, Tokarev VE. Method for determining the activity of catalase. Lab. Delo. 1988;1:16–9.
Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;2:248–54.
Lyon DY, Adams LK, Falkner JC, Alvarez PJ. Antibacterial activity of fullerene water suspensions: Effects of preparation method and particle size. J. Environ. Sci. Tech. 2006;40:4360–66.
Zhang B, Bian W, Pal A, He Y. Macrophage apoptosis induced by aqueous C60 aggregates changing the mitochondrial membrane potential. Environ Toxicol Pharmacol. 2015;39:237–46.
Song M, Liu S, Yin J, Wang H. Interaction of human serum album and C60 aggregates in solution. Int J Mol Sci. 2011;12:4964–74.
Gelderman MP, Simakova O, Clogston JD, Patri AK, Siddiqui SF, Vostal AC, et al. Adverse effects of fullerenes on endothelial cells: Fullerenol C60(OH)24 induced tissue factor and ICAM-1 membrane expression and apoptosis in vitro. Int J Nanomed. 2008;3:59–68.
Prylutska S, Bilyy R, Overchuk M, Bychko A, Andreichenko K, Stoika R, et al. Water-soluble pristine fullerenes C60 increase the specific conductivity and capacity of lipid model membrane and form the channels in cellular plasma membrane. J. Biomed. Nanotechnol. 2012;8:522–7.
Prylutska SV, Matyshevska OP, Grynyuk II, Prylutskyy YI, Ritter U, Scharff P. Biological effects of C60 fullerenes in vitro and in a model system. Mol. Cryst. Liq. Cryst. 2007;468:265–74.
Glatter O. A new method for the evaluation of small-angle scattering data. J. Appl. Cryst. 1977;10:415–21.
Svergun DI. Determination of the Regnlarization Parameter in Indirect-Transform Methods Using Perceptual Criteria. J. Appl. Cryst. 1992;25:495–503.
Prilutski Y, Durov S, Bulavin L, Pogorelov V, Astashkin Y, Yashchuk V, et al. Study of structure of colloidal particles of fullerenes in water solution. Mol.Cryst.Liq.Cryst. 1998;324:65–70.
Prylutskyy YuI, Durov SS, Bulavin LA, Adamenko II, Moroz KO, Geru II, et al. Structure and thermophysical properties of fullerene C60 aqueous solutions. Int. J. Thermophys. 2001;22:943–56.
Malafaia AB, Nassif PA, Ribas CA, Ariede BL, Sue KN, Cruz MA. Obesity induction with high fat sucrose in rats. Arq Bras Cir Dig. 2013;26:17–21.
Konukoğlu D, Serin O, Ercan M, Turhan MS. Plasma homocysteine levels in obese and non-obese subjects with or without hypertension; its relationship with oxidative stress and copper. Clin Biochem. 2003;36:405–08.
Prylutska SV, Grynyuk II, Matyshevska OP, Prylutskyy YI, Ritter U, Scharff P. Anti-oxidant properties of C60 fullerenes in vitro. Fullerenes, Nanotubes, Carbon Nanostruct. 2008;16:698–705.
Grant RW, Dixit VD. Adipose tissue as an immunological organ. Obesity (Silver Spring). 2015;23:512–18.
Lumeng CN, Saltiel AR. Inflammatory links between obesity and metabolic disease. J Clin Invest. 2011;121:2111–7.
Yang H, Youm YH, Vandanmagsar B, Ravussin A, Gimble JM, Greenway F, et al. Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic inflammation and insulin resistance. J Immunol. 2010;185:1836–45.
Nozdrenko DM, Zavodovsky DO, Matvienko TYu. C60 fullerene as promising therapeutic agent for the prevention and correction of functioning skeletal muscle at ischemic injury. Nanoscale Res Lett. 2017;12:115.
Bullard-Dillard R, Creek KE, Scrivens WA, Tour JM. Tissue sites of uptake of 14C-labeled C60. Bioorg Chem. 1996;24:376–85.
Peiris AN, Struve MF, Mueller RA, Lee MB, Kissebah AH. Glucose metabolism in obesity: influence of body fat distribution. J Clin Endocrinol Metab. 1988;67:760–7.
Peiris AN, Mueller RA, Smith GA, Struve MF, Kissebah AH. Splanchnic insulin metabolism in obesity. Influence of body fat distribution. J Clin Invest. 1986;78:1648–57.
Green CJ, Hodson L. The influence of dietary fat on liver fat accumulation. Nutrients. 2014;6:5018–33.
DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes. 1981;30:1000–7.
Evans DJ, Murray R, Kissebah AH. Relationship between skeletal muscle insulin resistance, insulin-mediated glucose disposal, and insulin binding. Effects of obesity and body fat topography. J Clin Invest. 1984;74:1515–25.
Nozdrenko D, Prylutskyy Yu, Ritter U, Scharff P. Protective effect of water-soluble pristine C60 fullerene in ischemia-reperfusion injury of skeletal muscle. Int. J. Physiol. Pathophysiol. 2014;5:97–110.
Prylutska S, Grynyuk I, Matyshevska O, Prylutskyy Y, Evstigneev M, Scharff P, et al. C60 fullerene as synergistic agent in tumor-inhibitory doxorubicin treatment. Drugs R D. 2014;14:333–40.
Afanasieva KS, Prylutska SV, Lozovik AV, Bogutska KI, Sivolob AV, Prylutskyy YuI, et al. С60 fullerene prevents genotoxic effect of doxorubicin on human lymphocytes in vitro. Ukr. Biochem. J. 2015;87:91–8.
Waki H, Tontonoz P. Endocrine functions of adipose tissue. Annu Rev Pathol. 2007;2:31–56.
Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860–7.
Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006;116:1793–801.
Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Ann. Rev. Immunol. 2011;29:415–45.
Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11:85–97.
Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest. 2007;117:175–84.
Lacey DC, Achuthan A, Fleetwood AJ, Dinh H, Roiniotis J, Scholz GM, et al. Defining GM-CSF- and macrophage-CSF-dependent macrophage responses by in vitro models. J Immunol. 2012;188:5752–65.
Winkler G, Dworak O, Salamon F, Salamon D, Speer G, Cseh K. Increased interleukin-12 plasma concentrations in both, insulin-dependent and non-insulin-dependent diabetes mellitus. Diabetologia. 1998;41:488.
Wegner M, Winiarska H, Bobkiewicz-Kozlowska T, Dworacka M. IL-12 serum levels in patients with type 2 diabetes treated with sulphonylureas. Cytokine. 2008;42:312–6.
O’Rourke RW, White AE, Metcalf MD, Winters BR, Diggs BS, Zhu X, et al. Systemic inflammation and insulin sensitivity in obese IFN-gamma knockout mice. Metabolism. 2012;61:1152–61.
Pollard KM, Cauvi DM, Toomey CB, Morris KV, Kono DH. Interferon-gamma and systemic autoimmunity. Discov Med. 2013;16:123–31.
Negrin KA, Roth Flach RJ, DiStefano MT, Matevossian A, Friedline RH, Jung D, et al. IL-1 signaling in obesity-induced hepatic lipogenesis and steatosis. PLoS One. 2014;9:e107265.
Dinarello CA. Blocking IL-1 in systemic inflammation. J Exp Med. 2005;201:1355–9.
Donath MY, Storling J, Berchtold LA, Billestrup N, Mandrup-Poulsen T. Cytokines and ß-cell biology: from concept to clinical translation. Endocr Rev. 2008;29:334–50.
Dellinger AL, Cunin P, Lee D, Kung AL, Brooks DB, Zhou Z, et al. Inhibition of inflammatory arthritis using fullerene nanomaterials. PLoS One. 2015;10:e0126290.
Conflict of interest
The authors report no potential conflicts of interest relevant to this article.
Rights and permissions
About this article
Cite this article
Halenova, T., Raksha, N., Vovk, T. et al. Effect of C60 fullerene nanoparticles on the diet-induced obesity in rats. Int J Obes 42, 1987–1998 (2018). https://doi.org/10.1038/s41366-018-0016-2
This article is cited by
Therapeutic effect of curcumin and C60 fullerene against hyperglycemia-mediated tissue damage in diabetic rat lungs
Journal of Bioenergetics and Biomembranes (2021)
Effect of the deuterium on efficiency and type of adipogenic differentiation of human adipose-derived stem cells in vitro
Scientific Reports (2020)
Evaluation of the Biocompatibility of Water-Soluble Pristine С60 Fullerenes in Rabbit